Vietnam Investment Review on MSN17h
Lion TCR s Liocyx M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV Related Hepatocellular Carcinoma
On 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an ...
Exelixis targets $5B Zanza sales by 2033 with multiple pivotal trials in progress
CEO Mike Morrissey highlighted significant momentum in 2024, emphasizing the company's goal of achieving $3 billion in annual cabozantinib (Cabo) revenue by 2030 and $5 billion for zanzalintinib ...
Zelenirstat cancer pill made in Alberta shows promising early results
Professor Luc Berthiaume has been working to find a cure for cancer for decades. "I came here to find a new way to kill ...
Arvinas anticipates Phase 3 topline results for vepdegestrant in Q1 2025 with commercial preparations underway
CEO John Houston emphasized that Arvinas is nearing key milestones, including the first Phase 3 topline data for vepdegestrant (vepdeg) from the VERITAC-2 trial expected in Q1 2025. He noted that this ...
How Do You Know If a Clinical Trial Is Right for You?
For Tammy Gusher Delgado, 56, the decision to join a clinical trial was clear. With a recent multiple sclerosis diagnosis and a clinical trial offering either the study drug or an approved ...
Updated drug information handout outdoes FDA's version in clinical trial
A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...